Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperfractionated accelerated radiochemotherapy with 5-FU + mitomycin C versus 5-FU + cisplatin in advanced head and neck cancer
2008-001584-11Phase 4Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in oropharyngeal cancer and head and neck cancer (HNC) comparing HART + 5-fluorouracil + mitomycin C with HART + 5-fluorouracil + cisplatin (2 arms). Primary endpoint: Overall survival improvement (cisplatin + 5-FU vs mitomycin C + 5-FU). Started Dec 2012; status: completed.
02
Drugs
cisplatinmitomycin cfluorouracil
03
Conditions
oropharyngeal cancerhead and neck cancer (HNC)
Beyond the preview
Go deeper on 2008-001584-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001584-11.